The legendary agency launched a $750 million early-stage fund concentrating on Sequence A startups and a $200 million seed fund.
Biotech Nephrogen combines AI and gene therapy to reverse kidney disease — check it out at TechCrunch Disrupt 2025
Oxford spinout RADiCAIT uses AI to make diagnostic imaging more affordable and accessible — catch it at TechCrunch Disrupt 2025
COI Energy solves a conundrum: Letting businesses sell unused electricity — catch it at TechCrunch Disrupt 2025